Whole exome sequencing identified a pathogenic nonsense mutation in LMNA in a family with a progressive cardiac conduction defect: A case report

Fan,Peng; Zhang,Di; Yang,Kun‑Qi; Tian,Tao; Luo,Fang; Liu,Ya‑Xin; Wang,Lin‑Ping; Zhou,Xian‑Liang

doi:10.3892/mmr.2020.11048

Whole exome sequencing identified a pathogenic nonsense mutation in LMNA in a family with a progressive cardiac conduction defect: A case report

Authors:
- Peng Fan
- Di Zhang
- Kun‑Qi Yang
- Tao Tian
- Fang Luo
- Ya‑Xin Liu
- Lin‑Ping Wang
- Xian‑Liang Zhou
View Affiliations

Affiliations: Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, P.R. China, Department of Emergency and Critical Care, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, P.R. China
Published online on: April 1, 2020 https://doi.org/10.3892/mmr.2020.11048
Pages: 2459-2465
Copyright: © Fan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Progressive cardiac conduction defect (PCCD) is an inherited autosomal dominant cardiac disorder characterized by an age‑dependent cardiac electrical conduction block. Several genes have been associated with the genetic pathogenesis of PCCD. The present study aimed to identify the causal mutation of PCCD and to investigate the association between genotype and phenotype in a Chinese family with PCCD. A total of 39 family members were included in the present study. All subjects participated in physical, biochemical, electrocardiography and echocardiography examinations. Whole‑exome sequencing was performed for four individuals from the same generation, including three patients with PCCD and one normal control with no cardiovascular disease. Sanger sequencing and in silico analysis were used to identify the causal mutation. Whole‑exome sequencing and variant identification revealed a candidate nonsense mutation (c.1443C>A, p.Tyr481*) in lamin A/C (LMNA). The mutation was identified in seven patients (including the proband) and two asymptomatic mutation carriers, but it was not detected in 100 control subjects of matched ancestry. Clinical examinations identified typical symptoms in patients with PCCD, including bradycardia and various types of conduction defect, and excluded other phenotypes related to the LMNA mutation. The genotype and phenotype were co‑associated among all participants. In the present study, the c.1443C>A mutation in the LMNA gene was identified as a potential cause of PCCD. In silico analysis predicted that the identified mutation was damaging through its effect on the lamin tail domain of LMNA. From the present study, it could be suggested that genetic screening and family counseling, early pacemaker implantation or a sudden death in the family may be essential for risk stratification and treatment of patients with PCCD.

View Figures

View References

1	Lenegre J and Moreau P: Chronic auriculo-ventricular block. Anatomical, clinical and histological study. Arch Mal Coeur Vaiss. 56:867–888. 1963.(In French). PubMed/NCBI
2	Lev M, Kinare SG and Pick A: The pathogenesis of atrioventricular block in coronary disease. Circulation. 42:409–425. 1970. View Article : Google Scholar : PubMed/NCBI
3	Kawaguchi T, Hayashi H, Miyamoto A, Yoshino T, Taniguchi A, Naiki N, Sugimoto Y, Ito M, Xue Q, Murakami Y and Horie M: Prognostic implications of progressive cardiac conduction disease. Circ J. 77:60–67. 2013. View Article : Google Scholar : PubMed/NCBI
4	Gourraud JB, Kyndt F, Fouchard S, Rendu E, Jaafar P, Gully C, Gacem K, Dupuis JM, Longueville A, Baron E, et al: Identification of a strong genetic background for progressive cardiac conduction defect by epidemiological approach. Heart. 98:1305–1310. 2012. View Article : Google Scholar : PubMed/NCBI
5	Baruteau AE, Probst V and Abriel H: Inherited progressive cardiac conduction disorders. Curr Opin Cardiol. 30:33–39. 2015. View Article : Google Scholar : PubMed/NCBI
6	Rankin JS and Ellard S: The laminopathies: A clinical review. Clin Genet. 70:261–274. 2006. View Article : Google Scholar : PubMed/NCBI
7	Rogozhina Y, Mironovich S, Shestak A, Adyan T, Polyakov A, Podolyak D, Bakulina A, Dzemeshkevich S and Zaklyazminskaya E: New intronic splicing mutation in the LMNA gene causing progressive cardiac conduction defects and variable myopathy. Gene. 595:202–206. 2016. View Article : Google Scholar : PubMed/NCBI
8	Lin F and Worman HJ: Structural organization of the human gene encoding nuclear lamin A and nuclear lamin C. J Biol Chem. 268:16321–16326. 1993.PubMed/NCBI
9	Mattout A, Dechat T, Adam SA, Goldman RD and Gruenbaum Y: Nuclear lamins, diseases and aging. Curr Opin Cell Biol. 18:335–341. 2006. View Article : Google Scholar : PubMed/NCBI
10	Mestroni L and Taylor MR: Lamin A/C gene and the heart: How genetics may impact clinical care. J Am Coll Cardiol. 52:1261–1262. 2008. View Article : Google Scholar : PubMed/NCBI
11	van Berlo JH, de Voogt WG, van der Kooi AJ, van Tintelen JP, Bonne G, Yaou RB, Duboc D, Rossenbacker T, Heidbuchel H, de Visser M, et al: Meta-analysis of clinical characteristics of 299 carriers of LMNA gene mutations: Do lamin A/C mutations portend a high risk of sudden death? J Mol Med (Berl). 83:79–83. 2005. View Article : Google Scholar : PubMed/NCBI
12	Hasselberg NE, Haland TF, Saberniak J, Brekke PH, Berge KE, Leren TP, Edvardsen T and Haugaa KH: Lamin A/C cardiomyopathy: Young onset, high penetrance, and frequent need for heart transplantation. Eur Heart J. 39:853–860. 2018. View Article : Google Scholar : PubMed/NCBI
13	Li H and Durbin R: Fast and accurate short read alignment with burrows-wheeler transform. Bioinformatics. 25:1754–1760. 2009. View Article : Google Scholar : PubMed/NCBI
14	DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, Philippakis AA, del Angel G, Rivas MA, Hanna M, et al: A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 43:491–498. 2011. View Article : Google Scholar : PubMed/NCBI
15	Wang K, Li M and Hakonarson H: ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38:e1642010. View Article : Google Scholar : PubMed/NCBI
16	Captur G, Arbustini E, Syrris P, Radenkovic D, O'Brien B, McKenna WJ and Moon JC: Lamin mutation location predicts cardiac phenotype severity: Combined analysis of the published literature. Open Heart. 5:e0009152018. View Article : Google Scholar : PubMed/NCBI
17	Kawakami H, Ogimoto A, Tokunaga N, Nishimura K, Kawakami H, Higashi H, Iio C, Kono T, Aono J, Uetani T, et al: A novel truncating LMNA mutation in patients with cardiac conduction disorders and dilated cardiomyopathy. Int Heart J. 59:531–541. 2018. View Article : Google Scholar : PubMed/NCBI
18	Captur G, Arbustini E, Bonne G, Syrris P, Mills K, Wahbi K, Mohiddin SA, McKenna WJ, Pettit S, Ho CY, et al: Lamin and the heart. Heart. 104:468–479. 2018. View Article : Google Scholar : PubMed/NCBI
19	Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, et al: 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the european society of cardiology (ESC). Endorsed by: Association for European paediatric and congenital cardiology (AEPC). Eur Heart J. 36:2793–2867. 2015. View Article : Google Scholar : PubMed/NCBI
20	Nishiuchi S, Makiyama T, Aiba T, Nakajima K, Hirose S, Kohjitani H, Yamamoto Y, Harita T, Hayano M, Wuriyanghai Y, et al: Gene-based risk stratification for cardiac disorders in LMNA mutation carriers. Circ Cardiovasc Genet. 10:e0016032017. View Article : Google Scholar : PubMed/NCBI
21	van Rijsingen IA, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast JF, van der Kooi AJ, van Tintelen JP, van den Berg WP, Pilotto A, Pasotti M, et al: Risk factors for malignant ventricular arrhythmias in lamin a/c mutation carriers a European cohort study. J Am Coll Cardiol. 59:493–500. 2012. View Article : Google Scholar : PubMed/NCBI
22	Ollila L, Nikus K, Holmstrom M, Jalanko M, Jurkko R, Kaartinen M, Koskenvuo J, Kuusisto J, Karkkainen S, Palojoki E, et al: Clinical disease presentation and ECG characteristics of LMNA mutation carriers. Open Heart. 4:e0004742017. View Article : Google Scholar : PubMed/NCBI
23	Brodt C, Siegfried JD, Hofmeyer M, Martel J, Rampersaud E, Li D, Morales A and Hershberger RE: Temporal relationship of conduction system disease and ventricular dysfunction in LMNA cardiomyopathy. J Card Fail. 19:233–239. 2013. View Article : Google Scholar : PubMed/NCBI
24	van Rijsingen IA, Nannenberg EA, Arbustini E, Elliott PM, Mogensen J, Hermans-van Ast AJ, van der Kooi AJ, van Tintelen JP, van den Berg MP, Grasso M, et al: Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers. Eur J Heart Fail. 15:376–384. 2013. View Article : Google Scholar : PubMed/NCBI
25	Du XJ: Gender modulates cardiac phenotype development in genetically modified mice. Cardiovasc Res. 63:510–519. 2004. View Article : Google Scholar : PubMed/NCBI
26	Babiker FA, De Windt LJ, van Eickel M, Grohe C, Meyer R and Doevendans PA: Estrogenic hormone action in the heart: Regulatory network and function. Cardiovasc Res. 53:709–719. 2002. View Article : Google Scholar : PubMed/NCBI
27	Nakajima K, Aiba T, Makiyama T, Nishiuchi S, Ohno S, Kato K, Yamamoto Y, Doi T, Shizuta S, Onoue K, et al: Clinical manifestations and long-term mortality in lamin A/C mutation carriers from a Japanese multicenter registry. Circ J. 82:2707–2714. 2018. View Article : Google Scholar : PubMed/NCBI
28	Walsh R, Thomson KL, Ware JS, Funke BH, Woodley J, McGuire KJ, Mazzarotto F, Blair E, Seller A, Taylor JC, et al: Reassessment of mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples. Genet Med. 19:192–203. 2017. View Article : Google Scholar : PubMed/NCBI
29	Ito K, Patel PN, Gorham JM, McDonough B, De Palma SR, Adler EE, Lam L, MacRae CA, Mohiuddin SM, Fatkin D, et al: Identification of pathogenic gene mutations in LMNA and MYBPC3 that alter RNA splicing. Proc Natl Acad Sci U S A. 114:7689–7694. 2017. View Article : Google Scholar : PubMed/NCBI
30	Pugh TJ, Kelly MA, Gowrisankar S, Hynes E, Seidman MA, Baxter SM, Bowser M, Harrison B, Aaron D, Mahanta LM, et al: The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing. Genet Med. 16:601–608. 2014. View Article : Google Scholar : PubMed/NCBI
31	Kitaguchi T, Matsubara S, Sato M, Miyamoto K, Hirai S, Schwartz K and Bonne G: A missense mutation in the exon 8 of lamin A/C gene in a Japanese case of autosomal dominant limb-girdle muscular dystrophy and cardiac conduction block. Neuromuscul Disord. 11:542–546. 2001. View Article : Google Scholar : PubMed/NCBI
32	Sylvius N, Bilinska ZT, Veinot JP, Fidzianska A, Bolongo PM, Poon S, McKeown P, Davies RA, Chan KL, Tang AS, et al: In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet. 42:639–647. 2005. View Article : Google Scholar : PubMed/NCBI
33	Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, Camm AJ, Ellinor PT, Gollob M, Hamilton R, et al: HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: This document was developed as a partnership between the heart rhythm society (HRS) and the European heart rhythm association (EHRA). Heart Rhythm. 8:1308–1339. 2011. View Article : Google Scholar : PubMed/NCBI
34	Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, et al: 2015 ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Rev Esp Cardiol (Engl Ed). 69:1762016.PubMed/NCBI
35	Pinto YM, Elliott PM, Arbustini E, Adler Y, Anastasakis A, Bohm M, Duboc D, Gimeno J, de Groote P, Imazio M, et al: Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: A position statement of the ESC working group on myocardial and pericardial diseases. Eur Heart J. 37:1850–1858. 2016. View Article : Google Scholar : PubMed/NCBI
36	Mogensen J, van Tintelen JP, Fokstuen S, Elliott P, van Langen IM, Meder B, Richard P, Syrris P, Caforio AL, Adler Y, et al: The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: A viewpoint paper of the European society of cardiology working group on myocardial and pericardial diseases and members of the European society of human genetics. Eur Heart J. 36:1367–1370. 2015. View Article : Google Scholar : PubMed/NCBI